XML 56 R44.htm IDEA: XBRL DOCUMENT v3.20.1
Subsequent Events (Details)
3 Months Ended 12 Months Ended
Mar. 23, 2020
$ / shares
shares
Jan. 02, 2020
$ / shares
shares
Jun. 25, 2019
$ / shares
Jan. 02, 2019
$ / shares
shares
Mar. 31, 2020
EUR (€)
Dec. 31, 2019
$ / shares
shares
Dec. 31, 2018
$ / shares
shares
Subsequent Event [Line Items]              
Options granted (in shares) | shares           1,089,000 1,120,500
Weighted average exercise price, granted (USD per share) | $ / shares           $ 2.26 $ 1.44
Subsequent Event              
Subsequent Event [Line Items]              
Research contract, expansion | €         € 700,000    
Research contract, expansion, term         19 months    
Executives and Key Personnel              
Subsequent Event [Line Items]              
Weighted average exercise price, granted (USD per share) | $ / shares       $ 1.87      
Executives and Key Personnel | Subsequent Event              
Subsequent Event [Line Items]              
Options granted (in shares) | shares   525,000          
Weighted average exercise price, granted (USD per share) | $ / shares   $ 5.27          
Executives and Key Personnel | Stock Option              
Subsequent Event [Line Items]              
Options granted (in shares) | shares       600,000      
Board of Directors              
Subsequent Event [Line Items]              
Options granted (in shares) | shares       300,000      
Weighted average exercise price, granted (USD per share) | $ / shares     $ 5.83 $ 1.87      
Board of Directors | Subsequent Event              
Subsequent Event [Line Items]              
Options granted (in shares) | shares   325,000          
Weighted average exercise price, granted (USD per share) | $ / shares   $ 5.27          
Board of Directors | Stock Option | Subsequent Event              
Subsequent Event [Line Items]              
Award vesting period   1 year          
Non-executive Employees | Subsequent Event              
Subsequent Event [Line Items]              
Options granted (in shares) | shares   23,000          
Weighted average exercise price, granted (USD per share) | $ / shares   $ 5.27          
Non-executive Employees | Stock Option | Subsequent Event              
Subsequent Event [Line Items]              
Award vesting period   4 years          
Consultant | Subsequent Event              
Subsequent Event [Line Items]              
Options granted (in shares) | shares 25,000 15,000          
Weighted average exercise price, granted (USD per share) | $ / shares $ 3.99 $ 5.27          
Consultant | Stock Option | Subsequent Event              
Subsequent Event [Line Items]              
Award vesting period 6 months 1 year          
Minimum | Executives and Key Personnel | Stock Option | Subsequent Event              
Subsequent Event [Line Items]              
Award vesting period   1 year          
Maximum | Executives and Key Personnel | Stock Option | Subsequent Event              
Subsequent Event [Line Items]              
Award vesting period   4 years